Please assess the completion status of the following clinical trial:

Trial Title: NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cranial nerve III (oculomotor nerve) and/or cranial nerve IV (facial nerve) palsy.~* Able to read and communicate in English.~Exclusion Criteria:~* Idiopathic onset of CN III and/or CN IV palsy.~* Traumatic injury to the eye or eyelid.~* Active wounds in the treatment area.~* Presence of swelling or infection in or surrounding the affected eye.~* Diminished sensation in the area to be treated.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EyeStim Group (Type: EXPERIMENTAL): Receive an active NMES treatment to the targeted muscles controlling eyelid function.
- Control Group (Type: SHAM_COMPARATOR): Undergo all the same procedures as the EyeStim group except receive a sham NMES treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).